Compare Bio Protocol (BIO) vs VeChain (VET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs VeChain — how do they compare? Bio Protocol trades at Rp514.49 (market cap Rp1,15T, Rp256,3M 24h volume), while VeChain trades at Rp87.52 (market cap Rp7,46T, Rp170,06M 24h volume). The key difference: VeChain is far larger — about 6.5× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 86B / 86,7B VET (100%) for VeChain. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and VeChain for 143 Days on average.
| BIO | VET | |
|---|---|---|
Market Cap | Rp1,15T | Rp7,46T |
Volume (24h) | Rp256,3M | Rp170,06M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 86B / 86,7B VET (100%) |
Typical Hold Time | 16 Days | 143 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VeChain (VET) is currently trading at Rp87.855 with a market cap of Rp7.51T, showing a bullish technical signal overall. The asset trades near its pivot point of Rp88, with immediate support at Rp86 and resistance at Rp89. Moving averages indicate a bullish trend, while oscillators remain neutral. The token is fully circulating with a 100% circulation rate and an average hold time of 143 days, suggesting moderate holding behavior among investors.
Overall outlook is cautiously optimistic given the bullish technical signals, but tempered by neutral oscillators. Key opportunity lies in a potential breakout above Rp89 resistance, which could target Rp91-93. Major risks include typical crypto volatility, regulatory uncertainty, and reliance on broader market sentiment. Investors should monitor support at Rp86 for any breakdown signals.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About VeChain
VeChain (VET) is a blockchain-powered supply chain platform. Launched in June 2016, VeChain aims to use distributed governance and Internet of Things (IoT) technology to create an ecosystem which solves some of the major problems with supply chain management.
Read more on VET →
